Alexion Pharmaceuticals has announced that it’s moving its corporate headquarters to Boston. The move is calling into question the state’s “First Five” business initiative that provides grants and loans to help companies relocate or grow in the state.
Alexion will turn its New Haven location into a research center in mid-2018 and will have about 450 employees there. There will be about 400 positions in Boston. The company said the reason for the move is a large biopharmaceutical talent pool and a variety of life-sciences partners that can help it grow. The departure comes on the heels of GE announcing it would move its corporate headquarters to Boston.
" Tip-Toe, Through The Feces......
Today, 07:54 AM in Mindless Moonbat Gibberish